- Kane Biotech press release (OTCQB:KNBIF): Q1 Net loss of C$1.22M
- Total revenue for the three months ended March 31, 2025 was C$412,513 compared to C$51,886 in the three months ended March 31, 2024.
Kane Biotech reports Q1 results

Related
Actuate Therapeutics: Elraglusib trial meets key endpoint in...
31 minutes ago
0
Trump administration is said to move to ease capital rules f...
42 minutes ago
0
Meyer Burger files for insolvency for 2 subsidiaries in Germ...
51 minutes ago
0
SA Asks: What are the best tech ETFs right now?
3 hours ago
0
Agco falls as Citi downgrades shares on valuation
4 hours ago
0
Popular
تصمیم مهم درباره سهمیه بازیکنان خارجی
4 days ago
2
© FBT Company 2025. All rights are reserved